Asan Medical Center: Carcinoma trials

The registry lists 19 Carcinoma studies with Asan Medical Center as lead sponsor. 1 are open to participants now and 1 have results posted.

Phase 2 11Phase 3 4No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Atezolizumab Plus Bevacizumab Alone or Combined with External Beam Radiotherapy for HCC with Macrovascular InvasionRecruitingNCT05992220Phase 2
• Gadoxetic Acid-MRI Versus Ultrasonography for the Surveillance of Hepatocellular Carcinoma in High-risk PatientsCompletedNCT01446666Results posted
• Association Between Pre-op Non-Selective Beta-Blockers and Hepatocellular Carcinoma Recurrence Post-Liver TransplantCompletedNCT06233708
• Lenvatinib After Progression on Atezolizumab-bevacizumab in Hepatocellular CarcinomaActive, not recruitingNCT06138769Phase 2
• Diagnostic Performance of [18F]FES PET/CT for Axillary LN Metastasis in Invasive Lobular CarcinomaCompletedNCT05960201Phase 2
• Combination of Regorafenib and Nivolumab in Unresectable Hepatocellular CarcinomaCompletedNCT04310709Phase 2
• Four Cycles Versus Six Cycles of Cisplatin-based Chemotherapy in Metastatic Urothelial CarcinomaStatus unknownNCT03296306Phase 3
• Pemetrexed Maintenance in Patients With Urothelial Carcinoma Who Completed First Line Platinum-based ChemotherapyStatus unknownNCT03193788Phase 3
• Needle Guiding Robot for Radiofrequency Ablation: Safety and Efficacy Study on Hepatocellular Carcinoma PatientsStatus unknownNCT03005756Not applicable
• The Effect of Telephone Counseling on the Compliance and Satisfaction for Advanced HCC Patients Receiving SorafenibStatus unknownNCT02564666Not applicable
• Quality of Life in Patients With Hepatocellular CarcinomaStatus unknownNCT02420678
• Efficacy and Safety of Concurrent TACE and Sorafenib in Patients With HCC and Extrahepatic Metastasis (COTSOM Study)Status unknownNCT02311205Phase 2
• Sorafenib vs.TransArterial Chemoembolization Plus RadioTherapy in Hepatocellular Carcinoma With Macrovascular InvasionCompletedNCT01901692Phase 2/3
• Role of Esophagectomy in Complete Responders to CCRTTerminatedNCT01740375Phase 3
• Pemetrexed and Cisplatin in Advanced Urothelial CarcinomaCompletedNCT01490437Phase 2
• Gemcitabine-Carboplatin Versus Gemcitabine-Oxaliplatin in Cisplatin-unfit Urothelial CarcinomaStatus unknownNCT01487915Phase 2
• Efficacy of Radiation Therapy and Transarterial Chemoembolization (TACE) to Treat Hepatocellular Carcinoma (HCC)WithdrawnNCT01432314Phase 2
• Trial Of Sunitinib In Advanced Non-Clear Cell Type Renal Cell CarcinomaStatus unknownNCT01219751Phase 2
• Study of Sunitinib Administered as 4/2 vs. 2/1 Schedule in Advanced Renal Cell Carcinoma (RCC)CompletedNCT00570882Phase 2